These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4989315)

  • 61. [Behavior of indanyl-carbenicillin (CP 15,464) following oral administration in man].
    Burgy C
    Schweiz Med Wochenschr; 1972 May; 102(21):732-8. PubMed ID: 4630209
    [No Abstract]   [Full Text] [Related]  

  • 62. Clinical experience with indanyl carbenicillin in urinary tract infections.
    Giamarellou E; Papazachos G; Piperakis G; Daikos G
    Curr Med Res Opin; 1976; 4(2):170-6. PubMed ID: 776540
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Application of lividomycin in urology].
    Mita T; Takahashi Y; Hara S; Ishigami J; Kobayashi M
    Jpn J Antibiot; 1972 Dec; 25(6):414-9. PubMed ID: 4579561
    [No Abstract]   [Full Text] [Related]  

  • 64. Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.
    Simon GL; Snydman DR; Tally FP; Gorbach SL
    Antimicrob Agents Chemother; 1980 Jul; 18(1):167-70. PubMed ID: 6448020
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Carbenicillin--a major new antibiotic.
    Nelson JD
    Am J Dis Child; 1970 Oct; 120(4):382-3. PubMed ID: 5493840
    [No Abstract]   [Full Text] [Related]  

  • 66. Carbenicillin: in-vivo synergism and combined therapy.
    Nunnery AW; Hamilton WD; Riley HD
    J Infect Dis; 1970 Sep; 122():Suppl:S78-83. PubMed ID: 5459953
    [No Abstract]   [Full Text] [Related]  

  • 67. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
    Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
    [No Abstract]   [Full Text] [Related]  

  • 68. The treatment of urinary-tract infections with an oral carbenicillin.
    Turck M
    J Infect Dis; 1973 May; 127():Suppl:133-5. PubMed ID: 4695478
    [No Abstract]   [Full Text] [Related]  

  • 69. Treatment of severe pseudomonas infections of the bronchi.
    Pines A; Raafat H; Siddiqui GM; Greenfield JS
    Br Med J; 1970 Mar; 1(5697):663-5. PubMed ID: 4986284
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical experience with amoxicillin in the treatment of skin infections.
    Pankey GA
    J Infect Dis; 1974 Jun; 129(0):suppl:S202-6. PubMed ID: 4276176
    [No Abstract]   [Full Text] [Related]  

  • 71. Piperacillin therapy for Pseudomonas infections.
    Eron LJ; Goldenberg RI; Poretz DM; Park CH
    South Med J; 1983 Jul; 76(7):859-62. PubMed ID: 6223378
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of carbenicillin against some microorganisms. Microbiological and electron microscopic studies].
    Jedlicková Z; Rýc M
    Arzneimittelforschung; 1969 Sep; 19(9):1513-7. PubMed ID: 4981209
    [No Abstract]   [Full Text] [Related]  

  • 73. Indanyl carbenicillin: chemistry and laboratory studies with a new semisynthetic penicillin.
    Butler K; English AR; Briggs B; Gralla E; Stebbins RB; Hobbs DC
    J Infect Dis; 1973 May; 127():Suppl:97-104. PubMed ID: 4571995
    [No Abstract]   [Full Text] [Related]  

  • 74. EFFECTIVENESS OF AMPICILLIN AGAINST GRAM-NEGATIVE BACTERIA. IN VITRO AND IN VIVO STUDIES OF A NEW ANTIBIOTIC.
    ANDERSON KN; KENNEDY RP; PLORDE JJ; SHULMAN JA; PETERSDORF RG
    JAMA; 1964 Feb; 187():555-61. PubMed ID: 14089001
    [No Abstract]   [Full Text] [Related]  

  • 75. Volunteer and clinical studies with carfecillin: a new orally administered ester of carbenicillin.
    Wilkinson PJ; Reeves DS; Wise R; Allen JT
    Br Med J; 1975 May; 2(5965):250-2. PubMed ID: 805625
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative non-blind trial of ceftriaxone and gentamicin in the treatment of complicated urinary tract infections.
    Lentini M; Castiello G; Scorza C; Calvosa F
    J Int Med Res; 1982; 10(3):166-78. PubMed ID: 6284564
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Beta-lactamine associations. In vitro synergism and clinical results].
    Acar JF
    Pathol Biol (Paris); 1971; 19(11):593-7. PubMed ID: 4997292
    [No Abstract]   [Full Text] [Related]  

  • 78. Human pharmacology of carbenicillin, a semisynthetic penicillin active against Pseudomonas aeruginosa.
    Robinson OP
    Antimicrob Agents Chemother (Bethesda); 1967; 7():614-8. PubMed ID: 5596198
    [No Abstract]   [Full Text] [Related]  

  • 79. Multidrug-resistant Proteus rettgeri: an emerging problem.
    Iannini PB; Eickhoff TC; LaForce FM
    Ann Intern Med; 1976 Aug; 85(2):161-4. PubMed ID: 1047989
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Obvious seizures from carbenicillin.
    Blum P; Matsen JM
    Minn Med; 1971 Sep; 54(9):697-9. PubMed ID: 4998525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.